Non-biological Extracorporeal Liver Replacement: Types and Indications

Main Article Content

Adrián Gadano
Guillermo Rosa Diez
Gustavo Grelon
Omar Galdame
Sebastián Marciano
Sergio Gianass
Salomón Algranati
Pablo Argibay

Abstract

.

Downloads

Download data is not yet available.

Article Details

Section

Update and advances in research

How to Cite

1.
Gadano A, Rosa Diez G, Grelon G, Galdame O, Marciano S, Gianass S, et al. Non-biological Extracorporeal Liver Replacement: Types and Indications. Rev Hosp Ital B.Aires [Internet]. 2010 Jun. 10 [cited 2026 Apr. 27];30(1):33-8. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1031

References

Rosa Diez g., gadano a. Reemplazo hepático extracorpóreo. en: Do Pico Jl, greloni g, giannasi se , et al. nefrología crítica. Buenos aires: Journal; 2009. p. 512-9.

cameron s. Breve historia de la hemodiálisis (1850-1970): hombres, materiales e ideas. en: Jofré R, lópez gómez JM, luño J, et al. tratado de hemodiálisis. Madrid: Jims; 2006. p. 1-37.

Davenport a. continuous renal replacement therapy for liver disease. Hemodial int. 2003;7(4):348-52. DOI: https://doi.org/10.1046/j.1492-7535.2003.00061.x

sen s, Williams R, Jalan R. emerging indications for albumin dialysis. am J gastroenterol. 2005;100(2):468-75 DOI: https://doi.org/10.1111/j.1572-0241.2005.40864.x

Mitzner sR, stange J, Klammt s, et al. improvement of hepatorenal syndrome with extracorporeal albumin dialysis MaRs : results of a prospective, randomized, controlled clinical trial. liver transpl. 2000;6(3):277-86. DOI: https://doi.org/10.1053/lv.2000.6355

Heemann u, treichel u, loock J, et al. albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology. 2002;36(4 Pt 1):949-58. DOI: https://doi.org/10.1016/S0270-9139(02)00102-7

Kreymann B, seige M, schweigart u, et al. albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol. 1999;31(6):1080-5 DOI: https://doi.org/10.1016/S0168-8278(99)80322-5

Chawla ls , georgescu F, abell B, et al. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. am J Kidney Dis. 2005;45(3):e51-6. DOI: https://doi.org/10.1053/j.ajkd.2004.11.023

Rosa Diez g, greloni g, gadano a, et al. combined extended haemodialysis with single-pass albumin dialysis (sPae D). nephrol Dial transplant. 2007;22(9):2731-2. DOI: https://doi.org/10.1093/ndt/gfm389

sauer iM, goetz M, steffen i, et al. in vitro comparison of the molecular adsorbent recirculation system (MaRs) and single-pass albumin dialysis (sPaD). Hepatology. 2004;39(5):1408-14. DOI: https://doi.org/10.1002/hep.20195

Peszynski P, Klammt s, Peters e, et al. albumin dialysis: single pass vs. recirculation (MaRs). liver. 2002;22 suppl 2:40-2. DOI: https://doi.org/10.1034/j.1600-0676.2002.00007.x

Kramer l, Bauer e, schenk P, et al. successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPsa -Prometheus). Wien Klin Wochenschr. 2003;115(15-16):599-603. DOI: https://doi.org/10.1007/BF03040456

Rifai K, ernst t, Kretschmer u, et al. Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol. 2003;39(6):984-90. DOI: https://doi.org/10.1016/S0168-8278(03)00468-9

evenepoel P, laleman W, Wilmer a, et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. artif Organs. 2006;30(4):276-84. DOI: https://doi.org/10.1111/j.1525-1594.2006.00215.x

Krisper P, Haditsch B, stauber R, et al. in vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43(3):451-7. DOI: https://doi.org/10.1016/j.jhep.2005.02.038

stadlbauer v, Krisper P, Beuers u, et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. asai O J. 2007;53(2):187-93. DOI: https://doi.org/10.1097/01.mat.0000249852.71634.6c

Krisper P, stauber Re. technology insight: artificial extracorporeal liver support--how does Prometheus compare with MaRs? nat clin Pract nephrol. 2007;3(5):267-76. DOI: https://doi.org/10.1038/ncpneph0466

Rifai K, Kribben a, gerken g, et al. extracorporeal liver support by fractionated plasma separation and adsorption (PROMet Heus ®) in patients with acute-onchronic liver failure (Heli Os study): a prospective randomized controlled multicenter study. J Hepatol 2010;52 suppl 1:s3. DOI: https://doi.org/10.1016/S0168-8278(10)60008-6

steiner c, Mitzner s. experiences with MaRs liver support therapy in liver failure: analysis of 176 patients of the international MaRs Registry. liver. 2002;22 suppl 2:20-5. DOI: https://doi.org/10.1034/j.1600-0676.2002.00003.x

grodzicki M, Kotulski M, leonowicz D, et al. Results of treatment of acute liver failure patients with use of the Prometheus FPsa system. transplant Proc. 2009;41(8):3079-81 DOI: https://doi.org/10.1016/j.transproceed.2009.08.024

Rifai K, Manns MP. Review article: clinical experience with Prometheus. ther apher Dial. 2006;10(2):132-7. DOI: https://doi.org/10.1111/j.1744-9987.2006.00354.x

Jalan R, sen s, steiner c, et al. extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol. 2003;38(1):24-31. DOI: https://doi.org/10.1016/S0168-8278(02)00334-3

Doria c, Mandalá l, smith J, et al. effect of molecular adsorbent recirculating system in hepatitis c virus-related intractable pruritus. liver transpl. 2003;9(4):437-43. DOI: https://doi.org/10.1053/jlts.2003.50055

Rifai K, Hafer c, Rosenau J, et al. treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus). scand J gastroenterol. 2006;41(10):1212-7. DOI: https://doi.org/10.1080/00365520600610154

Kellersmann R, gassel HJ, Bühler c, et al. application of Molecular adsorbent Recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. liver. 2002;22 suppl 2:56-8. DOI: https://doi.org/10.1034/j.1600-0676.2002.00011.x

Mullhaupt B, Kullak-ublick ga , ambühl P, et al. First clinical experience with Molecular adsorbent Recirculating system (MaRs) in six patients with severe acute on chronic liver failure. liver. 2002;22 suppl 2:59-62 DOI: https://doi.org/10.1034/j.1600-0676.2002.00012.x

Most read articles by the same author(s)

1 2 3 > >>